Joaquin Duato is a globally experienced, values-driven healthcare business leader and currently the Executive Vice President and Worldwide Chairman, Pharmaceuticals, at Johnson & Johnson, the world’s premiere healthcare company and fifth largest pharmaceutical business. He is a respected industry leader and is the Chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA). In recognition of his thought leadership, he was recently appointed to the Board of the CEO Roundtable on Cancer. Joaquin played an instrumental role in leading the dramatic turnaround of the Johnson & Johnson pharmaceuticals business. A 27-year veteran of the Company, Joaquin was named Company Group Chairman of the Americas in 2009. He then continued leading the global transformation upon his appointment as Worldwide Chairman in 2011. With a proven track record of creating innovative commercial solutions and processes to support the Company’s cutting-edge medicines, he inspires employees to focus on transforming the lives of patients. The results are clear: with 16 new products launched since 2009 and 10 potential billion dollar medicines expected to be filed before 2019, the Johnson & Johnson pharmaceuticals sector is poised to remain one of the fastest growing top 10 pharmaceutical companies globally. As a dual citizen of Spain and the US, Joaquin brings a unique international perspective to his work. With a career spanning three countries and two regions, he appreciates the value of diversity of experiences and perspectives. He brings this to bear externally as an active Board member of the US Spain Council and internally as the Executive Sponsor of the African American Leadership Council. His commitment to nurturing a culture of diversity was recognized in 2015 when he was named one of America’s Top 10 Hispanic Business Leaders by Hispanic Career World. Joaquin also has a passion for learning, with an undergraduate degree in economics and business, an MBA from ESADE, Barcelona and a Masters of International Management from Thunderbird, Phoenix. He is a champion of improving access to both health literacy and education more broadly through his role as Board member of the international charity Save the Children. He has served on the International Advisory Board of ESADE. In addition, he mentors MBA candidates at universities around the world and has spoken on leadership in the pharmaceutical industry at academic institutions including MIT, Columbia Business School and The Wharton School. Ultimately, Joaquin approaches every day with a clear sense of purpose and urgency, inspired by the words of Dr. Paul Janssen, “the patients are waiting.”

Pharmaceutics